tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market
ZBIO
Zenas BioPharma, Inc.
RESEARCH TOOLSreports

Zenas BioPharma, Inc. (ZBIO) Income Statement

268 Followers

Zenas BioPharma, Inc. Income Statement

Last quarter (Q4 2025), Zenas BioPharma, Inc.'s total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zenas BioPharma, Inc.'s net income was $-240.44M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 10.00M$ 5.00M$ 50.00M$ 0.00
Gross Profit
$ 9.94M$ -134.14M$ 50.00M$ -61.69M
Operating Expenses
$ 221.38M$ 29.75M$ 87.15M$ 14.51M
Depreciation and Amortization
$ 56.00K$ 137.00K$ 113.00K$ 78.00K
EBITDA
$ -211.33M$ -163.75M$ -27.03M$ -75.12M
Operating Income
$ -211.38M$ -163.89M$ -37.15M$ -76.20M
Other Income/Expenses
$ -166.43M$ 7.33M$ 324.00K$ -43.08M
Pretax Income
$ -377.82M$ -156.56M$ -36.82M$ -119.28M
Net Income
$ -377.74M$ -156.99M$ -37.12M$ -119.28M
Per Share Metrics
Basic EPS
$ -8.44$ -3.76$ -0.97$ -3.11
Diluted EPS
$ -8.44$ -3.76$ -0.97$ -3.11
Weighted Average Shares Outstanding
 44.73M 41.79M 38.32M 38.32M
Weighted Average Shares Outstanding (Diluted)
 44.73M 41.79M 38.32M 38.32M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History